Most clinicians consider tirzepatide 6-12 months after gastric sleeve surgery once post-surgical weight loss has stabilized, though timing should be individualized based on your metabolic response, nutritional status, and clinical needs
follow current UK SmPC for approved indications Patient monitoring should include regular assessment of: Body weight and composition to evaluate the effectiveness of weight management therapy Blood glucose levels , particularly in patients at risk of diabetes or with pre-existing diabetes Blood pressure , as both medications can affect cardiovascular parameters Gastrointestinal symptoms , ensuring tolerability of the combination Eye examinations for people with diabetes and pre-existing retinopathy, as rapid improvement in glucose control may temporarily worsen retinopathy Practical management strategies may help optimise outcomes: Timing Wegovy injections to minimise gastrointestinal side effects Implementing dietary modifications to support weight management despite steroid-induced appetite changes Ensuring adequate protein intake to counteract potential muscle loss from corticosteroids Maintaining physical activity as tolerated to support metabolic health Informing surgical teams about Wegovy use before procedures
The pounds come off because the drug changes your appetite and how fast your stomach empties, not because it tops up cellular energy
Weight loss doesnt have to seem like an impossible feat when you have support and options
Prader-Willi syndrome symptoms in early childhood With age, hypotonia tends to ease, while other PWS symptoms in infants may persist into early childhood
These changes include hyperlipidemia and increased gluconeogenesis
